Developer of therapeutics intended for the treatment of autoimmune diseases and cancer. GenEros is based in Hangzhou, China and was founded in 2018.
Team — not yet on record
No current team members for GenEros are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GenEros with a free account
- ·Watch GenEros: the Monday email on marks, rounds and moves